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Parkinson’s diseaseProduction of cellular reactive oxygen species (ROS) is typically associated with protein and DNA
damage, toxicity, and death. However, ROS are also essential regulators of signaling and work in
concert with redox-sensitive proteins to regulate cell homeostasis during stress. In this review,
we focus on the redox regulation of mitophagy, a process that contributes to energetic tone as well
as mitochondrial form and function. Mitophagy has been increasingly implicated in diseases includ-
ing Parkinson’s, Amyotrophic Lateral Sclerosis, and cancer. Although these disease states employ
different genetic mutations, they share the common factors of redox dysregulation and autophagic
signaling. This review highlights key redox sensitive signaling molecules which can enhance neuro-
nal survival by promoting temporally and spatially controlled autophagic signaling and mitophagy.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Reactive oxygen species (ROS) and other free radicals are typi-
cally associated with stress, DNA and protein damage, and used
as a marker of irrevocable damage and cell death. It has become
increasingly clear, however, that free radicals function as impor-
tant signaling molecules in response to stress [1,2] and modify pro-
tein structure and function in ways that are essential to adaptation
and survival. In this chapter we will discuss ROS production as a
consequence of aerobic respiration, how mitophagic containment
of injured organelles promotes cell survival and how impaired re-
dox regulation of autophagic signaling molecules leads to cell
dysfunction.Eukaryotic cells have evolved symbiotic relationships with
mitochondria to enhance energetic status and cellular and organis-
mal complexity. On average, eukaryotic cells contain one billion
ATP molecules, and the turnover from ATP to ADP and back occurs
approximately three times per minute [3]. The central nervous sys-
tem (CNS) relies on ATP generated primarily by aerobic respiration
and, as reviewed by Erecinska and Silver, the brain at rest utilizes
over 20% of total oxygen consumption and 0.3–0.8 lmol of glucose
per gram of weight per minute (lmol/g/min). The resulting ATP
production in neurons from consumed oxygen and glucose at rest
is approximately 25–32 lmol/g/min [4]. Neurons require high lev-
els of ATP – as much as 20–25 lmol/g/min – for maintaining mem-
brane polarity, rapid intra- and inter-cellular signaling, and
synaptic transmission. For example, neurons contain 6250 qmol
of the Na+/K+ pump/g of tissue (cardiac muscle contains only
1500–2000 qmol/g) [5] with the highest activity reported in syn-
aptosomes [6]. Neurons need 50–60% of total oxygen delivered to
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stasis alone. While the liver and heart consume more net ATP,
the only organ with comparable levels of energy expenditure for
membrane polarity and ionic balance is the kidney [7].
In addition to being the primary source of energy production in
the form of ATP, mitochondria produce the majority of free radicals
and other ROS. In studies measuring superoxide anions (O2) in rat
lung slices, about 9% of total oxygen uptake resulted in O2 forma-
tion, while other studies suggest that about 1–3% of oxygen used in
the mitochondria alone form O2. Neurons, especially those that
are most active and excitatory, have higher oxidative metabolic
activity and higher cristae packing density of mitochondria than
glia and other cell types [8]. Mitochondria are densely packed in
extended dendrites and axon terminals. The fact that neurons are
largely post mitotic places these cells under intense pressure to
promote appropriate mitochondrial biogenesis fusion, ﬁssion, and
mitophagy. Seminal work by Chang and Reynolds in 2006 aimed
to measure the turnover rate and number of mitochondria at base-
line in neurons. Interestingly, they found that mitochondria mor-
phology and trafﬁcking is dependent on the age of neurons [9].
For instance, a mature neuron at 14 days in vitro (DIV14) will con-
tain a similar amount of mitochondria as a young neuron at DIV5
(0.08 mitochondria/lm); however, mitochondria in mature neu-
rons are elongated and form reticular networks, whereas in young
neurons, mitochondria are shorter and more motile [9]. This differ-
ence in mitochondrial morphology with respect to neuron matu-
rity points to the temporal control of proteins governing
mitochondrial dynamics. David Chan pioneered work a decade
ago demonstrating that fusion and ﬁssion of mitochondria is coor-
dinated by essential proteins which are exquisitely sensitive to ge-
netic mutations and cellular stress [10]. In addition to maladaptive
changes in fusion and ﬁssion molecules, functional changes in
these proteins by redox modiﬁcation have increasingly been
appreciated as central regulators of mitochondrial function.
In the last ﬁve years, engulfment of damaged mitochondria by
molecules linked to autophagy has played a more prominent role
with respect to understanding the pathological cascades associated
with Parkinson’s disease, Amyotrophic Lateral Sclerosis (ALS), Alz-
heimer’s disease and other disorders. Autophagy is a highly con-
trolled process in which cells engulf proteins and organelles
within intracellular, lipid bilayer compartments and degrade con-
tents after fusion with lysosomes. The process was initially de-
scribed in yeast and now hundreds of proteins have been
associated with this highly complex pathway [11–13]. Autophagic
signaling can be promoted in response to a wide variety of stress-
ors including ionic dysfunction, protein aggregation and protea-
some failure, energetic stress and oxygen deprivation. Autophagy
can also be targeted toward speciﬁc organelles – notably the mito-
chondria – where they can undergo engulfment and digestion; a
process that is important given that mitochondria are both one
of the primary sources and sensitive targets of ROS. Moreover,
mitophagy may be particularly sensitive to ROS given that antiox-
idants, such as glutathione, can block mitophagy while autophagy
continues, as revealed in yeast models [14].2. Reactive oxygen species
2.1. ROS formation
Free radicals are a class of small molecules that contain one or
more unpaired electrons, rendering them highly reactive; those de-
rived from oxygen molecules are called reactive oxygen species
(ROS), and those from nitric oxide, reactive nitrogen species
(RNS). ROS are generated by a number of reactions promoted by
xanthine oxidase, microsomal enzymes, cyclooxygenase andlipoxygenase as well as more abundant mechanisms including
ROS produced by NADPH oxidases and the electron transport chain
(ETC) [15].
The activity of NADPH oxidases, membrane-associated enzymes
that utilize oxygen to catalyze the production of O2, is essential
for engulfment of injured cells and innate immunity. NADPH oxi-
dase deﬁciency is associated with X-linked chronic granulomatous
disease, a devastating disorder which leaves patients with poor im-
mune function [16]. Assembly of the NADPH complex at lysosomes
produces a large increase in oxygen consumption, referred to as a
‘‘respiratory burst’’. In response, superoxide dismutase (SOD) con-
verts O2 into hydrogen peroxide (H2O2), which kills off the en-
gulfed cells or particles. In addition, high concentrations of
catalase to detoxify H2O2, as in erythrocytes, are able to protect
other cells by absorbing diffused H2O2 [17] Another mechanism
for O2 clearance is via reaction with nitric oxide to produce per-
oxynitrite, which can subsequently be catalyzed to form hydroxyl
radicals.
The major source of ROS in aerobic cells, however, is cellular
respiration and oxidative phosphorylation within the mitochon-
dria. In the process of transferring electrons between the protein
complexes that mediate phosphorylation of ADP to ATP and reduc-
ing oxygen to water, the ETC generates free radicals. Electrons that
escape the ETC primarily through mitochondrial complexes I and
III transfer directly to oxygen to create O2 [18–20]. Due to the
high demand of ATP and increased oxidative phosphorylation to
meet that demand, neurons are particularly prone to generating
concentrated amounts of ROS. The intracellular environment of
neurons is thus highly reducing and, as will be further discussed,
contains various mechanisms to combat oxidation.
2.2. ROS modify speciﬁc amino acids
The location of amino acids within proteins is a central regula-
tor of protein function. Post-translational modiﬁcations , such as
lipidation or glycosylation, at speciﬁc amino acids alter protein
behavior through inactivation or enhancing activity or binding
with other proteins. Similarly, ROS serve as reversible post-transla-
tional modiﬁers of protein structure and function. Amino acid oxi-
dation can alter protein binding, interaction, and translocation or
confer previously unknown properties and binding partners. It is
helpful to realize that much like post-translational modiﬁcation
by phosphorylation, the structure and availability of amino acids
determines their vulnerability to ROS-mediated modiﬁcations.
Thiol groups are organosulfur compounds that contain a car-
bon-bonded sulfhydryl (–C–SH or R–SH) group (where R repre-
sents an alkane, alkene, or other carbon-containing group of
atoms). Proteins which contain these compounds are most easily
oxidized by ROS, RNS, and some metal ions. Oxidized thiol groups
can proceed to form thiyl radicals or disulphides. In fact, a third of
proteins synthesized by neurons contain disulﬁde bonds [21] that
are catalyzed by protein disulﬁde isomerases in the endoplasmic
reticulum [22].
The amino acids cysteine and methionine contain reactive thiol
groups that confer redox sensitivity to proteins. Similarly, the thiol
containing amino acid histidine makes it a target for singlet O2
reactions. Other less reactive amino acids include tyrosine, phenyl-
alanine, valine, proline, arginine, and tryptophan which can be oxi-
dized by oxygen radicals, forming peroxides and peroxyl radicals
[23]. Interaction with ROS causes these residues to break down
and generate highly reactive intermediate radicals.
While beyond the scope of this review, it should be noted that
reactive nitrogen species, such as nitric oxide, are also able to
post-translationally modify proteins to regulate their function by
S-nitrosylation [24]. Using site-speciﬁc mapping of S-nitrosylation
of cysteine residues in tissues of healthy mice, a recent study iden-
Table 1
Primary types of reactive oxygen species produced in neurons. ROS are primarily produced in aerobically dependent organisms due to inefﬁcient electron transfer in
mitochondria. Reduction of the highly reactive superoxide radical results in the formation of hydrogen peroxide, a more stable signaling molecule. Reduction of hydrogen
peroxide results in formation hydroxyl radicals. Each of these ROS can be detoxiﬁed by catalytic and non-catalytic antioxidants.
Reactive oxygen species Structure Reactivity Sources Detoxiﬁcation
Superoxide radical High Mitochondria, ETC
NOX isoforms
SOD
GSH
TrxNOS
Hydrogen peroxide Low Spontaneous reduction of O2
SOD reduction of O2
Catalase GPx
Hydroxyl radical Very high Breakdown of organic peroxides GSH
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regulate oxidative phosphorylation, glycolysis, and other pathways
for metabolism [25]. The authors report that 20–25% of S-nitrosy-
lated proteins were mitochondrial proteins in brain, liver, and kid-
ney tissues compared to 56% in heart tissue. In addition, when
comparing modiﬁed proteomes between wildtype and endothelial
nitric oxide synthase (eNOS) knockout mice, the group found that
mitochondrial proteomes were more than 70% dependent on eNOS
activity for S-nitrosylation, suggesting an important role for RNS in
normal metabolic regulation. Recent reviews [26,27] can be refer-
enced for more information on these molecules and the link be-
tween NO formation and inhibition of autophaghosome
formation in neurons [28].
2.3. ROS regulation & redox homeostasis
The tight regulation of ROS is key to energetic status, cell signal-
ing and responses to stress. The ways in which cells regulate redox
state include general mechanisms associated with increasing the
activity of antioxidants, as well as utilizing redox-sensitive en-
zymes to decrease ROS (summarized in Table 1). Furthermore,
tight spatial constraints on ROS can be enforced by organelles
and protein complexes, which localize ROS for efﬁcient removal
by co-localized antioxidants, such as thioredoxin and glutathione.
2.3.1. Endogenous non-enzymatic antioxidants reduce intracellular
ROS
The tripeptide glutathione (GSH; c–L-Glutamyl-L-cysteinylgly-
cine) is the most abundant low molecular weight thiol in mamma-
lian cells and constitutes a major cellular defense against ROS. In
the process of reduction, GSH is oxidized into glutathione disulﬁde
(GSSG) and can be reduced back to GSH via glutathione reductase.
In most cell types, the rate-limiting step for increasing GSH synthe-
sis is the uptake of cysteine. Interestingly, the CNS maintains an
enhanced GSH pool through enriched expression of the cysteine/
glutamate exchanger (xCT) in meningeal cells, as well as in both
neurons and astrocytes in cerebral cortex [29] offering enhanced
redox buffering in the CNS. GSH primarily acts as a ROS scavenger,
directly reducing hydroxyl radicals and superoxides. In addition,
GSH provides an essential function in the maintenance of other
reducing enzymes, such as vitamin C and E, by reducing them to
their active states.
While the redox status of neurons and other cells tends to be
viewed as a homogeneous environment, quite the opposite is true.
Thioredoxin (Trx) is a family of proteins that act as endogenous
reducing agents with an oxidizable dithiol active site that, after
activation, can be reduced back by thioredoxin reductase. Each
member of the Trx family exhibits speciﬁc intracellular localiza-
tion. For instance, Trx-1, the most abundant Trx protein in eukary-otes, is present in both the cytosol and nucleus, while Trx-2
localizes to mitochondria. Although they exist at a low intracellular
concentration – on the order of lmol – the Trx proteins may be
more speciﬁc than GSH in its rapid response to certain toxicants.
In response to H2O2, hypoxia [30], ischemic-reperfusion injury
[31,32], radiation [33,34], and other toxicants that increase intra-
cellular free radicals, Trx-1 translocates into the nucleus where it
can directly or indirectly associate with transcription factors, such
as nuclear factor kappa-light-chain-enhancer of activated B cells
(NFjB) [35] and activator protein 1 (AP-1) [36]. This compartmen-
talization of Trx may serve as a discreet mechanism of protection,
functioning as a ROS scavenger at the nucleus and as a regulator of
gene expression under stress. Also contributing to compartmental-
ized areas of ROS regulation, the mitochondria-speciﬁc Trx-2 inter-
acts with components of the ETC and is thought to play a role in
regulating mitochondrial membrane potential [37,38] and mito-
chondrial permeability transition pore activity [39]. Furthermore,
Trx-2 directly reduces H2O2 as a peroxiredoxin cofactor, whereas
GSH contributes minimally to H2O2 clearance [40,41]. Thus, despite
minute overall concentration compared to GSH, Trx serves as an
essential redox regulator through distinct antioxidant roles in
mitochondria and nuclei, as well as in speciﬁc peroxide clearance.
2.3.2. Redox-sensitive enzymes catalyze antioxidant processes
In addition to non-catalytic antioxidants, several catalytic pro-
teins also contribute to the regulation of redox homeostasis. The
SOD family of enzymes, ﬁrst discovered by Fridovich and McCord
[42] are metal coordinating enzymes that play major roles in the
enzymatic reduction of O2 into oxygen and H2O2. Cytoplasmic
copper/zinc superoxide dismutase (CuZnSOD) and mitochondria-
localized manganese superoxide dismutase (MnSOD) are both
active participants in this process. Both enzymes are highly
expressed in neurons, and overexpression of either enzyme de-
creases tissue damage after focal ischemia in animal models
[43,44]. Furthermore, mutations in these enzymes lead to deﬁcien-
cies in buffering ROS and are linked to familial forms of ALS [45].
Catalases are a group of proteins that consist of four protein
subunits that contain a buried heme group. Molecules small en-
ough to travel through narrow channels leading to the heme center
are then reduced. Catalases primarily reduce small molecules such
as H2O2, utilizing a reaction mechanism by which one H2O2 is re-
duced to a water molecule and another oxidized to an oxygen mol-
ecule. Catalases are especially active within peroxisomes, which
contain enzymes that create H2O2. Subcellular localization of cata-
lases at organelles of high H2O2 production highlights the ways in
which cells tightly regulate redox state. However, mitochondria
contain very little catalase, thus any H2O2 generated by the mito-
chondria must either diffuse to peroxisomes or rely on other anti-
oxidant defenses [46].
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dase (GPx) that removes H2O2 by reducing it to a water molecule
and simultaneously oxidizing a reduced glutathione. Like GSH,
GPx is localized primarily to the cytosol but it is also found in mito-
chondria, which would assist in the removal of H2O2 generated
from this organelle.
Localized concentrations of antioxidants may also play a signif-
icant role in mitophagic signaling. Interestingly, ethacrynic
acid-induced depletion of GSH promoted mitophagy in yeast under
conditions of starvation [14]. Conversely, increases in the GSH pool
by addition of the antioxidant N-acetyl-L-cysteine prevented
mitophagy during starvation, but did not impact autophagy [14].
The authors hypothesized that mitophagy was being impacted by
the spatial and temporal and localization of GSH.Fig. 1. Oxidation of PTEN promotes autophagic and mitophagic signaling. ROS
reversibly oxidize PTEN allowing for prolonged PI3K/Akt signaling in response to
growth factor receptor stimulation. Downstream targets of Akt stimulation include
pro-survival transcription factors, such as FoxO1 and FoxO3. Transport of FoxO1 out
of the nucleus initiates autophagosome formation by Atg recruitment. FoxO3 is
known to target pro-autophagic genes promoting autophagosome formation.3. Redox regulation of autophagic signaling
The activation of autophagy and mitophagy is tightly regulated
by molecular rearrangement, such as protein conformational
changes and complex formation, and protein localization to initiate
the transcription of autophagy related genes (Atgs). Increased gen-
eration of ROS promotes autophagy via oxidative modiﬁcation of
proteins involved in either the autophagic machinery or in signal-
ing pathways that enhance autophagy.
3.1. Oxidatively-modiﬁed proteins change function to promote
autophagy
3.1.1. ROS inhibition of PTEN increases Akt signal transduction to
regulate FoxO transcription factors
Cellular redox status impacts lipids and protein signal transduc-
tion much in the same way that other forms of post-translational
modiﬁcations do. As modiﬁers of protein activity, oxidative modi-
ﬁcations impact neuronal mitophagy and potentially serve as
essential regulators of cell growth, signaling and fate.
One example of the impact of redox status on cell fate decisions
is the effect of ROS on growth factor mediated signaling. Molecules
such as vascular endothelial growth factor (VEGF) and neuronal
growth factor (NGF) activate signaling cascades to promote cell
survival signaling by activation of the PI3K/Akt pathway [47,48].
Activation of the PI3K/Akt pathway promotes transcription of
pro-survival genes, and the main regulatory member of this cas-
cade is Phosphatase and Tensin homologue (PTEN), a tyrosine
phosphatase that normally dephosphorylates PI3K, decreasing
Akt signal transduction. Akt is a serine/threonine-speciﬁc protein
kinase which promotes cell survival by inhibition of apoptosis
and activation of transcription factors that increase expression of
genes that regulate cell survival, proliferation, metabolism, and
migration [49].
PTEN is oxidatively modiﬁed by H2O2, which produces a disul-
ﬁde bond in the PTEN active site. Oxidation of PTEN by H2O2 leads
to reversible inactivation of PTEN activity, prolonging PI3K and Akt
association – an effect that promotes cell survival in the presence
of high H2O2 concentrations in vitro [50] and in in vivo models of
ischemia where the reperfusion stress of ﬂooding a system with
oxygen causes a burst of ROS [51]. Additionally, studies in which
Akt signaling is inhibited demonstrate that mitochondrial derived
ROS production increases promoting autophagy [52]. Moreover,
modiﬁcation of Akt by ROS can be adaptive by increasing the nu-
clear export of Forkhead box protein O1 (FoxO1), driving the pro-
duction of antioxidant enzyme Trx. This signaling loop combats
further increases in ROS [50] and enhances the activity of Atg fam-
ily proteins and facilitating autophagic signaling.
In addition to the indirect effects of PTEN modiﬁcation on Akt,
the Forkhead family of proteins also responds to Akt signaling.The Forkhead transcriptional regulators play diverse roles in
eukaryotic cell growth, differentiation, and survival. Indeed, the
mammalian FoxO family was initially identiﬁed as essential tumor
suppressors [53,54] and are direct substrates of Akt. When Akt
phosphorylates FoxO transcription factors, both proteins are
exported from the nucleus to the cytoplasm via a nuclear export
sequence. Following Akt phosphorylation, FoxOs interact with
14-3-3 proteins promoting the cytoplasmic localization of FoxO
and alterations in cell signaling independent of DNA binding.
Direct interacting partners of FoxOs include other transcription
factors, such as b-catenin and Smad, HOX proteins, and hormone
receptors [55].
Engagement of FoxO transcription has been increasingly associ-
ated with the induction of autophagy-related genes, underscoring
the importance of these proteins and the autophagic pathway in
mutagenesis and oncogenic transformation [56]. FoxO3 upregu-
lates genes such as Beclin 1, ATG12, ATG4, LC3, and others, with
essential roles in autophagic recognition, containment, engulfment
and digestion [57]. FoxO3 is a positive regulator of BNIP3 expres-
sion – a mitochondrially associated protein that promotes auto-
phagosome formation in cell culture models of skeletal muscle
atrophy [57] as well as mitophagy in animal models of hypoxia
[58].
In yeast, FoxO1 stimulates autophagy via interaction with Atg7
upon acetylation by Sirtuin-2, a redox sensitive transcription factor
[59]. Using mammalian cells, the same group found FoxO3 pro-
motes FoxO1-mediated autophagy, wherein FoxO3 upregulates
PI3K subunit expression, thus increasing Akt activity [60]. In conse-
quence, FoxO1 is exported from the nucleus, where it then pro-
motes its pro-autophagic activity [59,60]. Taken together, these
data support a model in which redox status of the cell is capable
of directly modifying a sentinel protein to promote autophagy
via growth factor engagement, kinase activation, transcriptional
regulation and subcellular relocalization of proteins and protein
complexes (Fig. 1).
3.2. ROS regulate ATG activity
The ATG genes in yeast and respective homologues in mammals
are the primary initiators and regulators of autophagy. Seminal
work in yeast has shown that nutrient depletion causes vacuoles
to ﬁll with autophagosomes, a process initiated by inactivation of
Tor, and that mutations of the ATG gene family disrupted that pro-
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increased autophagic signaling, but also with changes in redox
homeostasis and oxidative stress. Eisler et al. showed that pro-
longed amino-acid depletion induces apoptosis, as well as high
concentrations of ROS. The group also showed that 40% of starving
cells survived despite having high ROS, indicating that ROS is not a
consequence of apoptosis, but rather a signal to initiate this pro-
cess [64].
ROS is also a signaling mechanism for autophagy during acute
starvation. In in vitro models of acute starvation, Scherz-Shouval
et al. demonstrated that autophagosome formation depended on
increases in ROS. Speciﬁcally, the activity of Atg4, a cysteine prote-
ase, was shown to be inhibited by treatment with H2O2. Under
ideal growth conditions, Atg4 removes an arginine residue of
Atg8, allowing Atg8 to be activated by Atg7. With H2O2 treatment
Atg4 becomes oxidized at speciﬁc cysteine residues, rendering it
inactive and allowing Atg8 to conjugate with autophagosomes
[65].
Autophagy and mitophagy share some similar proteins, but oth-
ers, such as Atg32, a newly identiﬁed mitochondrial outer mem-
brane protein which interacts with Atg11, promotes the
autophagy machinery speciﬁcally for mitophagy [66,67]. Notably,
no metazoan homologues of Atg32 have been identiﬁed, but other
molecules that work with Atg homologues in eukaryotic organisms
such as NIX (also called BNIP3L), integrate redox sensitivity with
organelle degradation mediated by Atg8 [68,69].
3.3. Oxidative modiﬁcation of proteins that alter mitochondrial
bioenergetic function
Some of the earliest and most well characterized molecules that
have been linked to oxidative stress signaling include the serine ki-
nase p66shc. This protein is a member of the Shc family which plays
important roles in oncogenic transformation and cell signaling. Un-
like other Shc family members, p66shc has evolved a glycine and
proline-rich second collagen homology domain (CH2), which con-
fers a unique ability to sense redox stress. Phosphorylation at ser-
ines 36 and 54 within the CH2 domain in response to oxidative
stress results in changes in protein structure required for p66shc’s
ability to serve as a redox sensing signaling molecule. In addition,
cysteine 59 in the CH2 domain is the target of reversible, speciﬁc
amino acid oxidation that promotes the bioactivity of p66shc allow-
ing the formation of tetramers [70]. Polymorphisms in the protein
are linked with long life [71], and mice that lack p66shc live 30%
longer than wildtype animals [72] and have a signiﬁcantly de-
creased redox burden as they age.
Phosphorylation of Ser36 of p66shc is promoted by protein ki-
nase Cb. Once phosphorylated, this redox sensitive molecule binds
to Pin1, a prolyl hydroxylase [73]. p66shc then relocalizes to the
intermembrane space of the mitochondria. p66shc activation in re-
sponse to oxidative stress is rapid; our group has found Ser36
phosphorylation of p66shc occurs within 30 min after sublethal
oxygen and glucose deprivation in neurons and mitochondrial
localization is maximal 2–3 h after initiation of stress [2]. Once
localized to mitochondria, p66shc oxidizes cytochrome c in cell free
assays which is thought to promote ETC production of H2O2, and
impair the ability of mitochondria to buffer calcium [74].
While these effects of p66shc activity have largely been associ-
ated with apoptosis, our group has identiﬁed p66shc as a discrete
but essential mediator of neuronal metabolic tone and autophago-
some formation as an adaptive mechanism to promote the removal
of injured organelles following low level oxygen and glucose depri-
vation [2]. Indeed, interruption of p66shc activity during mild stress
profoundly increased lipid and protein injury as well as the num-
ber of and autophagosomes that form. These events were all corre-
lated with poor outcomes for neurons and a reduction in the abilityto upregulate the expression of neuroprotective chaperone pro-
teins [2]. This data supports a model in which we have come to
appreciate that oxidative modiﬁcation of proteins such as p66shc
is not synonymous with cell death, but this modiﬁcation serves
as a rapid means to promote communication from the cytosol back
to the mitochondria. Indeed, localization to mitochondria of acti-
vated p66shc suggests this protein may be one of several molecules
that temporally and spatially mediate mitochondria homeostasis,
as well as mitophagy.
3.4. Oxidatively-modiﬁed transcription factors alter activity to
promote autophagy
3.4.1. SIRT1 is oxidatively modiﬁed to regulate autophagy
While cytosolic signaling molecules like Akt and p66shc promote
unique redistribution in response to ROS, nuclear transcription fac-
tors also play essential roles in autophagic regulation. Notably,
mammalian sirtuins function as important regulators of metabo-
lism, cell survival, growth, and senescence. Sirtuins – mammalian
homologues of yeast silent information regulator 2 (Sir2) – are
Class III histone deacetylases that respond to a variety of stressors
and are involved in protection against several diseases and aging.
The most well-studied is Sirtuin 1 (SIRT1). Several seminal studies
point to SIRT1’s capability of attenuating age-related deﬁciencies
and protecting against oxidative stress [75].
SIRT1 mRNA is especially high in the developing CNS and heart.
While most sirtuins are expressed at high levels in the brain, the
most extensively studied are SIRT1[76], which is primarily located
in neurons, and SIRT2, which is primarily located in oligodendro-
cytes and Schwann cells [75]. SIRT1-deﬁcient mice exhibit pro-
found developmental abnormalities, including cardiac defects,
exencephaly, and perturbed retinal histology [77]. Tissues cultured
from these mice contain heavily damaged mitochondria and im-
paired metabolic function [78]. SIRT1 deacetylase also complexes
with Atg5, Atg7, and Atg8 leading to comparisons between the
SIRT1/ phenotype with ATG5/ cells and animals [78,79]. Trans-
genic animals deﬁcient in either protein displayed similar deﬁcien-
cies in autophagy, lending the idea that SIRT1 deacetylase activity
may be important for Atg function.
SIRT1 also acts as an indirect regulator of autophagic processes
via regulation of FoxO and p53 (Fig. 1). Sirt1 forms a complex with
FoxO3 in response to oxidative stress, deacetylating FoxO3 to fur-
ther promote cell survival via increased DNA binding and activa-
tion of FoxO3 target genes [80].
3.3.2. ROS can increase HIF1a-mediated autophagic signaling and
mitophagy
A cell’s ability to sense intracellular oxygen levels is critical for
cell survival and adaptation. The primary sensors of oxygen levels
within the cell are prolyl hydroxylase domain-containing enzymes
(PHDs) and hypoxia-inducible factors (HIFs) [81,82]. When oxygen
supply is ideal, PHDs hydroxylate proline residues on HIFa sub-
units [83]. Hydroxylated HIF is then ubiquitinated by the E3 ubiq-
uitin ligase von Hippel-Lindau protein (pVHL) and is subsequently
degraded. In low oxygen conditions, however, PHDs decrease activ-
ity, stabilizing HIF and inducing transcription of target genes such
as vascular endothelial growth factor, cyclooxygenase-2, and
erythropoietin [84].
Several studies demonstrated that mitochondrial ROS regulate
HIF proteins at the level of pVHL induced degradation and expres-
sion of genes regulated by HIF such as metallothionein. Using both
pharmacological and genetic techniques, Brunelle and colleagues
subjected HEK293 cells to hypoxia following inactivation of mito-
chondrial complex III and demonstrated a rapid increase in HIF1a
degradation [85]. Although ROS is not required for HIF transcrip-
tion, the authors of these studies posit that ROS generated by the
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lyl hydroxylase activity [86]. In addition, a separate study found
that a functional ETC and mitochondria-derived ROS are necessary
for hypoxia-induced HIF1a stabilization [87].
This model, however, is limited to mild hypoxia. During periods
of anoxia,HIF canbe stabilized in theabsenceROS.Other studiespro-
vide evidence for HIF1a as an essential cofactor for metallothionein
gene transcription in response to hypoxic stress [88]. Metallothio-
nein proteins are potent oxidant scavengers which regulate heavy
metal sequestration and metabolism. Triggers such as NO promote
the release of zinc from metallothioneins which can be a potent
means to induce apoptotic cell death in neurons. Furthermore, ele-
vated levels of ROS following hypoxic stress can stimulate zinc re-
lease frommetallothioneines, which inhibits further HIF1a activity.
HIFs are essential transcriptional regulators of genes with essen-
tial functions in energymetabolism and vascular remodeling which
optimizeavailableoxygenandglucose.HIF stabilizationalso aides in
autophagic signaling via transcription of BNIP3 and BNIP3L, which
are members of the so-called BH3-only subfamily of Bcl-2 family
proteins that heterodimerize and antagonize the activity of the lar-
gelyprosurvival proteins (Bcl-2 andBcl-XL), Semenzaand colleagues
presented convincing evidence that hypoxia-induced HIF1a stabil-
izationand regulationofBNIP3 reduced thenumberofmitochondria
in hypoxic cells through mitophagy [89]. The mechanism proposed
involves elevated BNIP3 in competition with Beclin-1 for binding
with Bcl2. BoundBcl2–BNIP3 increases levels of free Beclin-1,which
then triggers formation of autophagosomes. Similar reports from
other groups revealed that bothBNIP3 andBNIP3L are crucial for hy-
poxia-induced autophagy through disruption of Bcl2-Beclin1 bind-
ing [90]. Additionally, rodent models of hypoxia tolerance
demonstrate that BNIP3expression is strongly correlatedwithmito-
chondrial clearance and mitophagic signaling in cardiac tissue
depending on the degree of hypoxia [58].
Taken together, redox status of the cell is a key factor in deter-
mining HIF1a stability and thus regulation of downstream modu-
lators of autophagy and mitophagy (Fig. 2).Fig. 2. ROS inhibit PHD activity to promote autophagy and mitophagy via HIF-
regulated transcription. Hypoxia and reperfusion increase production of ROS by
perturbing oxidative phosphorylation. ROS inhibit the HIF1a degrading PHD
complex, increasing expression of cytosolic HIF1a. HIF1a relocalizes to the nucleus
when associated with HIF1b, targeting pro-survival genes, including BNIP3 and
BNIP3L as well as pro-death molecules based on the extent and duration of oxygen
deprivation. When BNIP3L is synthesized, it associates with mitochondria com-
plexes with Bcl2 in competition with Beclin1. The liberation of Beclin1 promotes
autophagosome formation.Although these and other studies of hypoxia-induced signaling
have been essential to understanding cellular response to oxygen
levels and ROS, it is important to remember that neurons rely
heavily on oxygen levels, which in turn promotes high levels of
ROS within the CNS. This effect is compounded by the largely
post-mitotic nature of these cells. Although hypoxic conditions dis-
rupt neuronal metabolic and redox tone, not all neurons are
equally vulnerable to hypoxia; for instance, CA1 hippocampal neu-
rons are some of the most sensitive [91]. At sea level, atmospheric
oxygen is approximately 20%, but oxygen present in vivo in tissue
is lower than ambient oxygen [92]. Furthermore, levels of oxygen
vary between tissue in vivo (20–40 mmHg) [93], cells in vivo (1–
10 mmHg) and cells grown in culture (150 mmHg) [94], providing
yet another caveat to studying the consequences of hypoxic stress.
Therefore, in attempting to capture the CNS responses to hy-
poxia, our group – among others – is particularly cautious in using
immortalized cell lines. These mitotic cultures are primarily glyco-
lytic, although they can be forced to rely on oxidative phosphory-
lation for ATP production by substituting glucose with galactose
[95]. This discrepancy makes the use of primary cultures for the
investigation of hypoxia-dependent signaling far more appealing
from a physiological standpoint.
4. Conclusions
In summary, ROS-mediated signaling may occur independently
of cell death mechanisms and may instead promote survival by
activating speciﬁc regulators of mitophagy and autophagy. ROS
working in concert with target redox-sensitive proteins is another
facet of intracellular signaling that impacts the ways in which we
study neuropathological diseases associated with high concentra-
tions of ROS. In order to expand this area of study, better methods
for differentiating between mitophagy and autophagy are needed.
Klionsky and colleagues recently released guidelines for studying
autophagy [96], yet the identiﬁcation of methods speciﬁcally tar-
geting mitophagy is limited. As for studying ROS-mediated signal-
ing, many groups have taken advantage of redox sensors, such as
dyes and ﬂuorescent markers, as well as free radical spin traps to
inhibit ROS [97]. Additionally, novel methods for isolating redox-
sensitive proteins can be coupled with mass spectrometry to iden-
tify proteins oxidized at speciﬁc amino acids [98,99]. This method
holds promise in pin-pointing modiﬁed protein targets that would
affect the pathways involved following cellular stress. Further-
more, the connection between in vivo and in vitro disease models
for oxidative stress and neuropathological disease must be re-eval-
uated and tuned more toward recapitulation of physiological
conditions.
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